 |
|
|
| |
The Effect of Hepatic Impairment on the Safety, Pharmacokinetics, and Antiviral Activity of GS-7977 in Hepatitis C Infected Subjects Treated for Seven Days
|
| |
| |
Reported by Jules Levin
EASL 2012 Barcelona Spain Apr 18-22
E. Lawitz1, M. Rodriguez-Torres2, M. Cornpropst3, J. Denning3, D. Clemons3, L. McNair3, L. Fang4, M. Berrey5, W. Symonds3
1Alamo Medical Research, San Antonio, TX, USA, 2Fundacion de Investigacion, San Juan, USA, 3Gilead Sciences, Inc., Durham, NC, USA, 4Pharstat, Inc., Research Triangle Park, NC, USA,5Pharmasset, Inc., Durham, NC, USA
|
| |
|
|
|
|
|
